Journal Article DZNE-2026-01207

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Highly Reproducible Quantification of Serum Neurofilament Light Chain in a Multi-Center Study.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
Wiley-Blackwell Oxford [u.a.]

European journal of neurology 33(11), e70803 () [10.1111/ene.70803]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Neurofilament light chain measured in serum (sNfL) is an emerging biomarker for neuro-axonal injury, but its clinical use requires robust reference values and demonstration of inter-laboratory comparability.This round-robin study aimed to assess age-dependent sNfL using the Quanterix HD-X Analyzer under laboratory conditions that were strictly standardized across all participating sites to exclude technical outliers while providing reference values on an absolute scale. Besides a group of individuals with relapsing-remitting multiple sclerosis (RRMS, n = 24) we measured a cohort of voluntary blood donors (n = 128) to revisit age-related cut-off values under strict laboratory conditions. Measurements were performed in five German laboratories following a standardized protocol, and all reagents and consumables derived from identical kit lots.In line with previous work, we found that sNfL increased with age by about ~0.15 pg/mL per year within the sampled donor age range of 21-60 years. Also, our results demonstrate that measurements obtained across different laboratories exhibited a high degree of comparability with an average coefficient of variation of 11%. Using quantile regression with identical age-dependent thresholds across sites, we observed consistent, exploratory separation of the small MS cohort from healthy donors (mean AUC 0.79, 95% CI 0.68-0.88).Our findings support the analytical robustness as well as inter-laboratory comparability of sNfL measurements and its use as a serum biomarker in multi-center studies of neurodegeneration.

Keyword(s): Humans (MeSH) ; Neurofilament Proteins: blood (MeSH) ; Adult (MeSH) ; Middle Aged (MeSH) ; Male (MeSH) ; Female (MeSH) ; Biomarkers: blood (MeSH) ; Reproducibility of Results (MeSH) ; Young Adult (MeSH) ; Cohort Studies (MeSH) ; Multiple Sclerosis, Relapsing-Remitting: blood (MeSH) ; Reference Values (MeSH) ; Age Factors (MeSH) ; immunoassay ; multiple sclerosis ; neurofilament proteins ; reference values ; relapsing–remitting ; reproducibility of results ; Neurofilament Proteins ; neurofilament protein L ; Biomarkers

Classification:

Contributing Institute(s):
  1. Parkinson Genetics (AG Gasser)
  2. Clinical Study Center (Ulm) (Clinical Study Center (Ulm))
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Database coverage:
Medline ; DOAJ ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DEAL Wiley ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > UL DZNE > UL DZNE-Clinical Study Center (Ulm)
Document types > Articles > Journal Article
Institute Collections > TÜ DZNE > TÜ DZNE-AG Gasser
Documents in Process
Public records
In process

 Record created 2026-11-20, last modified 2026-11-20


Restricted:
Download fulltext PDF Download fulltext PDF (PDFA)
External link:
Download fulltextFulltext by Pubmed Central
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)